SCHWARTZ JONATHAN DAVID (Chief Medical Officer) sold 0.8% of their position (2.54K shares) of ROCKET PHARMACEUTICALS, INC. on the open market
Open‑market sale worth $7.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 11/20/2025ACC: 0001140361-25-042856
Officer· Chief Medical Officer
Since Jan 2019
-2.54K
Net shares
Net seller
$7.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
2.54K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−2.54K
Price / share
$2.98
Trade value
$7.59K
% of position
0.8%
11/18/2025
301.61K→299.06K
Total
Net shares
−2.54K
Net value
-$7.59K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/18/2025 | S · Sale | −2.54K | $2.98 | $7.59K | 0.8% | 301.61K | 299.06K |
| Total | −2.54K | -$7.59K | ||||||
Derivative Transactions0
No derivative transactions reported